{"paper_id":"8d7b27a4-f177-48fb-bfcb-155e55595945","body_text":"Patient Report\nEfficacy of Norethisterone in Patients with Ovarian Endometrioma\nNorethisterone for treatment of endometriosis\n2017 Volume 60 Issue 3 Pages 182-185\nDetails\nAbstract\nEndometriosis is a chronic inflammatory disorder associated with pelvic pain and infertility. Because surgical and medical therapies control symptoms, but it is hard to cure completely endometriosis, long term of pharmacologic management is necessary. Norethisterone (NET), one of progestins, has safety profile and advantage that allow long-term use. In this preliminary report, we showed the efficacy of NET in 6 patients with endometriosis. The size of ovarian endometrioma was decreased after treatment with NET for 6 months, and all patients were relieved from dysmenorrhea pain within 6 months, suggesting that NET would be a suitable medication to treat endometriosis.\n© 2017 Tottori University Faculty of Medicine\nFavorites & Alerts\nRecently viewed articles","source_license":"CC0","license_restricted":false}